Document is current
Any future updates will be listed below
-
Authors
Fisse, Anna Lena https://orcid.org/0000-0003-0493-8656
May, Caroline
Motte, Jeremias
Pedreiturria, Xiomara
Breuer, Thomas G. K.
Schneider-Gold, Christiane
Marcus, Katrin
Gold, Ralf
Yoon, Min-Suk
Pitarokoili, Kalliopi
-
Funding
Funding for this research was provided by:
Georgius Agricola Stiftung Ruhr, Bochum, Germany
Ruhr-Universität Bochum
- License Information
-
More Information
Article History
Received: 18 August 2020
Accepted: 30 October 2020
First Online: 24 November 2020
Conflict of interest
: Anna Lena Fisse received honoraria and travel grants from Novartis AG, Sanofi and Eisai GmbH, none related to this work and owns shares of Fresenius SE & Co., Gilead Sciences, Medtronic PLC and Novartis AG. Caroline May received funding from PURE (Protein Research Unit Ruhr within Europe, a project of North Rhine Westphalia, a federal German state) and deNBI, a project of the German Federal ministry of Education and Research [FKZ031A534A], none related to this work. Jeremias Motte received travel grants from Biogen idec, Novartis AG, Teva and Eisai GmbH; his research is funded by Klaus Tschira Foundation and Ruhr-University, Bochum (FoRUM-program), none related to this work. Xiomara Pedreiturria: none. Thomas G. K. Breuer: none. Christiane Schneider-Gold received consulting and speaker’s honoraria from Alexion Pharmaceuticals, Amicus Therapeutics, Bayer Schering, CSL Behring, Grünenthal, Lupin Pharmaceuticals, and TEVA. Katrin Marcus received funding from PURE (Protein Research Unit Ruhr within Europe, a project of North Rhine Westphalia, a federal German state) and deNBI, a project of the German Federal ministry of Education and Research [FKZ031A534A], none related to this work. Ralf Gold received consultation fees and speaker honoraria from Bayer Schering, Biogen idec, Merck Serono, Novartis, Sanofi-Aventis and TEVA. He also acknowledges grant support from Bayer Schering, Biogen idec, Merck Serono, Sanofi-Aventis and TEVA, none related to this manuscript. Min-Suk Yoon received speakers’ honoraria from CSL Behring, Grifols and scientific grant from CSL Behring. Kalliopi Pitarokoili received travel grants and speakers’ honoraria from Novartis, Biogen idec, Teva, Bayer, CSL Behring and Grifols all not related to the manuscript.
: The ethics committee of the medical faculty of the Ruhr University Bochum approved our study protocol (vote no. 16-5994).
: Written informed consent was obtained by patients or their legal representatives.
: Open Access funding enabled and organized by Projekt DEAL.
